4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Fractyl Health, Inc. (GUTS) operates in the Biotechnology industry and is headquartered in Burlington, United States with about 100 employees. Its market capitalization is roughly $126 million. In the fiscal year ended 2025-12-31, GUTS reported $0M in revenue and ($141M) in net income.
Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Gross Profit | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($97M) | ($94M) | ($51M) | ($49M) | — |
| Net Income | ($141M) | ($69M) | ($77M) | ($46M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Gross Profit | — | $0M | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($21M) | ($23M) | ($23M) | ($26M) | ($25M) | — |
| Net Income | $9M | ($44M) | ($46M) | ($28M) | ($24M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $121M | $108M | $76M | $61M | — |
| Total Liabilities | $112M | $80M | $401M | $313M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive GUTS viewer.
About TickerBase · Data methodology & sources